FIRST MANHATTAN CO. LLC. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2016$5,000
-28.6%
3,0000.0%0.00%
Q1 2016$7,000
-86.0%
3,000
-14.3%
0.00%
Q2 2014$50,000
+38.9%
3,5000.0%0.00%
Q1 2014$36,000
+44.0%
3,500
+40.0%
0.00%
Q4 2013$25,000
+177.8%
2,5000.0%0.00%
Q3 2013$9,0002,5000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2016
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,547,248$3,729,0000.20%
Broadfin Capital, LLC 825,986$1,991,0000.19%
PURA VIDA INVESTMENTS, LLC 159,877$385,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$3,170,0000.14%
FT Options LLC 50,600$122,0000.13%
Lombard Odier Asset Management (USA) Corp 231,974$559,0000.08%
SABBY MANAGEMENT, LLC 385,248$928,0000.05%
Integre Asset Management, LLC 57,501$139,0000.04%
BLUESTEIN R H & CO LLC 185,975$448,0000.03%
Alambic Investment Management, L.P. 33,880$82,0000.03%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders